Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul V Fish

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Medicinal Chemistry|January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceMark D Andrews, Paul V Fish, Julian Blagg, et al.
ACS Chemical Biology|August 30, 2017
Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast DifferentiationJulia C Meier, Cynthia Tallant, Oleg Fedorov, et al.
Nature|June 3, 2021
NOTUM from Apc-mutant cells biases clonal competition to initiate cancerDustin J Flanagan, Nalle Pentinmikko, Kalle Luopajärvi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cellsDalia Barsyte-Lovejoy, Fengling Li, Menno J Oudhoff, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Medicinal Chemistry|January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceMark D Andrews, Paul V Fish, Julian Blagg, et al.
ACS Chemical Biology|August 30, 2017
Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast DifferentiationJulia C Meier, Cynthia Tallant, Oleg Fedorov, et al.
Nature|June 3, 2021
NOTUM from Apc-mutant cells biases clonal competition to initiate cancerDustin J Flanagan, Nalle Pentinmikko, Kalle Luopajärvi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cellsDalia Barsyte-Lovejoy, Fengling Li, Menno J Oudhoff, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Pageof 6